Investors with Losses of $100,000 can contact the law firm at no cost to learn more about recovering their losses
LOS ANGELES, Aug. 10, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Kiromic BioPharma, Inc. (“Kiromic” or the “Company”) (NASDAQ: KRBP) investors that a class action filed on behalf of investors. Kiromic investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
The Complaint alleges that the Offering Documents failed to disclose that the FDA had, before the filing of the Registration Statement and Prospectus, imposed a clinical hold, and in fact, contained statements indicating that it had not. Given that the Offering closed on July 2, 2021, more than thirty (30) days after the Company submitted the IND applications for its two immunotherapy product candidates, investors were assured that no clinical hold had been issued and clinical trials would commence.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com
Attorney Advertising
![](https://ml.globenewswire.com/media/MDAxYWNiOGMtMWUzMi00YWFiLWIyY2MtZGE4NTU2ZjY4YzBhLTEyMDcwODA=/tiny/Portnoy-Law.png)